OT PING METER
Report
- Report Number
- 2939301-2010-08376
- Event Type
- Malfunction
- Date Received
- September 23, 2010
- Report Date
- September 16, 2010
- Manufacturer
- LIFESCAN, INC.
- Product Code
- MDS
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- OTHER
Narratives
LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT; 510 (K) # IS K082590.
THE LAY USER/PATIENT'S PRODUCT(S) HAS BEEN RETURNED AND EVALUATED BY LIFESCAN PRODUCT ANALYSIS WITH THE FOLLOWING FINDINGS: THE METER INVOLVED IN THIS CASE FAILED TESTING. THE METER WAS FOUND TO HAVE CRACKED/BROKEN DISPLAY. IF ANY ADDITIONAL INFORMATION IS AVAILABLE, THE FDA WILL BE NOTIFIED IN A SECOND FOLLOW UP REPORT. AT THIS TIME, WE CONSIDER THIS MATTER CLOSED.
THE LAY USER/PATIENT CONTACTED LIFESCAN ALLEGING THE METER HAS BLACK MARKS IN THE DISPLAY. THE ISSUE WAS NOT RESOLVED WITH TROUBLESHOOTING. THERE WERE NO ALLEGATIONS OF HARM OR INJURY. REPLACEMENT PRODUCTS WERE SENT TO THE PATIENT.
A PATIENT CONTACTED OUR (B)(4) AFFILIATE TO REPORT DEVELOPING A CORNEAL ULCER WHILE WEARING 1-DAY ACUVUE TRUEYE CONTACT LENSES, NARAFILCON A. NARAFILCON A LENSES ARE NOT MARKETED IN THE U.S. THE PATIENT SAID HE/SHE WAS DIAGNOSED WITH A CORNEAL ULCER. THE TREATING ECP, WHO DID NOT FIT THE PATIENT WITH 1-DAY TRUEYE LENSES, TOLD THE PATIENT THAT THE CONTACT LENSES MAY NOT HAVE FIT CORRECTLY. A FACE TO FACE INTERVIEW AT THE TREATING CLINIC PROVIDED THE FOLLOWING INFORMATION: ON (B)(6) 2010, THE PATIENT PRESENTED TO THE CLINIC COMPLAINING OF OD PAIN, REDNESS, WATERY EYE AND PHOTOPHOBIA. THE PATIENT WAS FOUND TO HAVE A 1 MM X 1 MM CORNEAL INFILTRATE AT THE OD SUPERIOR LIMBUS. THE INFILTRATE WAS CIRCULAR IN SHAPE. THE INFILTRATE WAS DETERMINED TO BE INFECTIOUS; A CULTURE WAS NOT PERFORMED. THE PATIENT'S VA WAS 1.5 AND WAS NOT AFFECTED. THE PATIENT WAS TREATED WITH BESTRON EYE DROPS, TARIVID EYE OINTMENT AND HYALEIN EYE DROPS. ON (B)(6) 2010, THE PATIENT RETURNED TO THE CLINIC, "THE INFILTRATE MUCH IMPROVED, BUT THE LESION SLIGHTLY REMAINED." THE PATIENT DID NOT RETURN TO THE CLINIC, THE INFILTRATE WAS CONSIDERED TO BE RESOLVED. NO ADDITIONAL INFORMATION PROVIDED. PRODUCT WAS NOT RECEIVED. THIS IS BEING REPORTED AS A SERIOUS ADVERSE EVENT DUE TO THE REPORT OF AN INFECTIOUS CORNEAL INFILTRATE. A LOT HISTORY REVIEW WAS PERFORMED, THE RESULTS REVEALED THE FOLLOWING: THE BATCH RECORD DID NOT SHOW ANY ABNORMALITIES IN MONOMER AND SOLUTION TESTING. ALL PARAMETERS TESTED WERE WITHIN SPECIFICATION. ALL STERILIZATION REQUIREMENTS WERE SUCCESSFULLY COMPLETED. IF ADDITIONAL INFORMATION IS RECEIVED, WILL REPORT WITHIN 30 DAYS OF RECEIPT. MDR REPORTABLE EVENT TRENDS ARE REVIEWED QUARTERLY IN EXECUTIVE MANAGEMENT REVIEW MEETINGS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | OT PING METER | GLUCOSE MONITORING SYS/KIT | MDS | LIFESCAN, INC. | 2990683 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |